| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $147,412,544 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01CA272487 | A Phospholipid-Derived Nanotherapeutic Platform for Improved Colorectal Cancer Immunochemotherapy | 000 | 4 | NIH | 5/11/2026 | $343,517 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | T32NR022238 | Training in Health Research for Innovative Vital Healthcare (THRIVE) | 000 | 1 | NIH | 7/2/2026 | $211,128 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01AG087952 | TDP-43 LLPS and mitochondrial dysfunction in neurodegeneration | 000 | 2 | NIH | 5/27/2026 | $640,743 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HD109310 | The role of Alpha1-Adrenergic Receptors Promoter Methylation in Cerebral Autoregulation in Fetus | 000 | 4 | NIH | 5/7/2026 | $383,750 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | UH3EB034686 | Development of a combined Gamma/Positron system for molecular imaging of the human brain at sub-500 micron spatial resolution | 001 | 4 | NIH | 8/12/2026 | $904,452 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01DC022866 | Cochlear neuron functions and diseases | 000 | 2 | NIH | 8/7/2026 | $660,873 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | UG3CA290443 | Investigating novel targets for topical immunoprevention of keratinocytic skin cancer | 000 | 2 | NIH | 7/22/2026 | $455,188 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R35GM156786 | Uncovering how chaperones assist in protein folding and preventing toxic protein aggregates | 000 | 2 | NIH | 7/24/2026 | $373,504 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | F31NS141379 | Characterizing clearance mechanisms of TDP-43 and disease associated isoforms | 000 | 2 | NIH | 7/24/2026 | $50,114 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01NS145389 | Molecular mechanism for pharmacological activation of KCa2 channels | 001 | 2 | NIH | 5/14/2026 | $585,091 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | R33DA059889 | Methadone Patient Access to Collaborative Treatment (MPACT) | 000 | 4 | NIH | 8/14/2026 | $1,140,286 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HD118973 | Revealing Cilia Function in the Human Fallopian Tubes | 000 | 2 | NIH | 5/14/2026 | $598,570 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | T32DK138883 | Interdisciplinary training in diabetes and metabolism research | 000 | 2 | NIH | 5/15/2026 | $240,612 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01DK133196 | Glyoxalase 1 and its Role in Metabolic Syndrome | 000 | 4 | NIH | 3/19/2026 | $473,132 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HL175366 | Hexokinase 1 mitochondrial binding and its role in cardiac endothelial cell function and the development of HFpEF | 000 | 2 | NIH | 5/14/2026 | $725,502 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01DE034985 | Harnessing immune-epithelial interactions to promote restoration of salivary gland function after IR | 000 | 2 | NIH | 6/19/2026 | $639,992 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01ES035965 | Wildland-Urban Interface Fire Exposures, Effects, and Interventions: A Collaborative Research-to-Action Partnership with Firefighters | 000 | 3 | NIH | 5/8/2026 | $754,855 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01AG075122 | PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial | 000 | 5 | NIH | 5/25/2026 | $1,353,297 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01DA055075 | Neural circuit regulation of ramping activity in dopamine neurons | 000 | 5 | NIH | 5/12/2026 | $349,500 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01AG079924 | Investigating the Role of Hepatic Glucagon Receptor Signaling in Healthspan and Aging | 000 | 3 | NIH | 5/8/2026 | $603,657 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | P30ES006694 | Southwest Environmental Health Sciences Center | 000 | 29 | NIH | 5/22/2026 | $1,522,817 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HD110994 | Vaginal Microbiome, Inflammatory Mediators, Metabolome, and Dysmenorrhea Symptom-based Phenotypes | 000 | 5 | NIH | 6/10/2026 | $560,132 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01DK136661 | Hypothalamic regulation by thyroid hormone receptor phosphorylation | 000 | 5 | NIH | 6/17/2026 | $604,846 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HL142769 | Defining mechanisms of CC16 on epithelial-driven host responses to pathogens | 000 | 8 | NIH | 8/6/2026 | $589,772 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R37AG053589 | Aging and Estrogenic Control of the Bioenergetic System in Brain | 000 | 10 | NIH | 3/26/2026 | $537,250 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01MH132806 | Translational Approach to Studying miRNA functions in sACC and amygdala in patients with BPD | 000 | 3 | NIH | 7/6/2026 | $743,673 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | T32GM132008 | Computational and Mathematical Modeling of Biomedical Systems | 000 | 6 | NIH | 6/9/2026 | $431,337 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01CA268383 | Targeting Lysosomal Vulnerabilities in Renal Pathogenesis | 000 | 5 | NIH | 5/15/2026 | $480,833 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01AA032555 | Hepatocyte FOXA3 in Alcohol-Associated Liver Disease | 000 | 2 | NIH | 6/26/2026 | $641,238 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R35HL184262 | Decoding the enigma of cardiac arrhythmia and mechanosensitivity | 000 | 1 | NIH | 7/3/2026 | $558,127 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HL182883 | The interaction of myosin and the thin filament: how sarcomeric mutations cause allosteric dysfunction and their connections to genetic cardiomyopathies | 000 | 1 | NIH | 7/10/2026 | $650,419 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HL178607 | The roles of endoplasmic reticulum stress in calcium-dependent cardiac arrhythmias | 000 | 1 | NIH | 7/10/2026 | $577,065 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01GM151371 | Identifying and modulating mechanistic cellular paths of quiescence deepening and transition to senescence | 000 | 1 | NIH | 5/13/2026 | $1,386,390 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HL180762 | Endothelial-Mediated Genetic Risk for Vascular Disease | 000 | 1 | NIH | 8/12/2026 | $778,582 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R21AI198872 | Trained immunity induced by repeated vaccination | 000 | 1 | NIH | 8/11/2026 | $233,250 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R35GM161300 | Establishing Glyoxalase 2 as a Viable Target for the Treatment of Disease | 000 | 1 | NIH | 5/18/2026 | $407,323 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01NS147431 | Defining how neurons drive CNS toxoplasmosis outcomes | 000 | 1 | NIH | 5/19/2026 | $711,256 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | R01AG102624 | Development of selective Dyrk1a Inhibitors for Alzheimer's disease | 000 | 1 | NIH | 8/18/2026 | $611,338 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R35GM161426 | Bioinspired Design Principles for Clearance-Resistant and Stress-Responsive Therapeutic Microcarrier | 000 | 1 | NIH | 5/19/2026 | $376,481 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01NS148267 | Aggregation and TDP-43-associated mitochondrial dysfunction and neurodegeneration | 000 | 1 | NIH | 8/12/2026 | $530,105 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01DE036160 | Innovative Methods for Next-Generation Evidence Synthesis in Oral Health Research | 000 | 1 | NIH | 8/5/2026 | $371,900 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | K99HL188210 | Developing Nanoplatforms for Co-Delivery of Drugs and Genes to Protect Lung Endothelium from Injury | 000 | 1 | NIH | 8/12/2026 | $108,950 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | F31NR022365 | Autonomic Regulation, Vascular Adaptation, and the Conditions of Daily Life: Insights into Hypertensive Disorders of Pregnancy | 000 | 1 | NIH | 8/18/2026 | $53,114 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R21CA299160 | Endogenous HOCl-derived chloramines in skin inflammation and photocarcinogenesis | 000 | 1 | NIH | 5/19/2026 | $399,712 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R56AI201174 | Anti-viral defense by natural microbial environmental agents | 000 | 1 | NIH | 8/12/2026 | $806,740 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R25AI189409 | The National Summer Undergraduate Research Project: Virtual Programming and Mentoring in Biomedical Microbiology and Immunology | 000 | 1 | NIH | 5/18/2026 | $368,681 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01CA299298 | Interrogating Niche-specific Nuclear and Extra-Nuclear Estrogen Receptor-alpha (ER) Signaling to Prevent ER+ Breast Cancer Progression in ER+ Bone | 000 | 1 | NIH | 7/10/2026 | $545,195 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R13ES038007 | 5th National Conference on Per- and Polyfluoroalkyl Substances | 000 | 1 | NIH | 5/19/2026 | $30,000 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01CA304024 | Enteric Glial Cell Reprogramming by Loss of MENIN in Duodenopancreatic Neuroendocrine Tumors | 000 | 1 | NIH | 8/13/2026 | $581,288 |
|
